1Coleman MP, Babb P, Mayer D, Quinn MJ, Sloggett A. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS Region (CDROM). London: Office for National Statistics, 1999
2Cancer in Leicestershire, Annual Report of the Director of Public Health 1995/1996
Leicestershire Health. Leicester: 1996
3Grannis F. History of Cigarette Smoking and lung cancer.
4Lindsey Jarvis, Office for National Statistics. Smoking among secondary school children in 1996: England. London: The Stationery Office, 1997
5Borio G . A capsule History of Tobacco. http://www.tobacco.org/History/Tobacco_History.html
6Underwood J, Britton R. General and systematic pathology. Edinburgh: Churchill Livingstone, 1992.
7McGee, Isaacson P, Wright N. Oxford textbook of pathology. Oxford: Oxford University Press, 1992.
8WHO Histological Typing of lung cancers 2nd ed. 1981Geneva/London
9Shepherd FA. Alternatives to chemotherapy and radiotherapy as adjuvant treatment for lung cancer. lung cancer. 1997; 17(1): S121-S136.
10Weller M. Insurance, reinsurance and underwriting names' liability for asbestos-related diseases. Medicine, Science & the Law. 1992; 32(1): 23-34.
11Roland M, Rudd R. Genetics and pulmonary medicine – 7: Somatic mutations in the development of lung cancer, Thorax 1998; 53(11):979-983
12Harris CC Chemical and physical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res 1988; 50:25-70
13Barbacid M. ras genes. Annu Rev Biochem 1987; 56:779-827
14Bouck N. Tumour angiogenesis: the role of oncogenes and tumour suppressor genes. Cancer Cells 1990; 2:179-185
15Liotta LA, Stegg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-336
16Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253:49-53
17Takashi T, Takashi H, Suzuki H et al. The p53 gene is frequently mutated in small-cell lung cancer with a distant nucleotide substitution pattern. Oncogene 1990; 6:1775-8
18Chiba I, Takashi T, Nau MM et al. Mutations in the p53 gene are frequent in primary, resected non-small-cell lung cancer. Oncogene 1990; 5:1603-10
19 Halevy O, Michalovitz D, Oren M. Different tumor-derived p53 mutants exhibit distinct biological activities. Science 1990; 250:113-116
20Lee J, Mao L, Hong W. Biology of preneoplastic lesions. In: Roth J, Cox J, Hong W eds. lung cancer 2nd Ed. Oxford: Blackwell Science, 1998
21Cox G, Steward P, O’Byrne K. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 1999; 54:169-179
22Muller F. Tobacco Misuse and Lung carcinoma. University of Cologne’s Pathological Institute, 1939
23Levin M, Goldstein H, Gerhardt P. Cancer and Tobacco Smoking: A preliminary Report. JAMA 1950; 143(4):336-38
24Wynder E, Graham E. Tobacco smoking as a possible etiological factor in bronchogenic carcinoma: A study of 684 proved cases. JAMA 1950; 143(4):329-36
25Doll R, Hill AB. Smoking and Carcinoma of the lung. BMJ 1950; ii:739-48
26Doll R, Hill AB. Mortality in relation to smoking. 10 years observations of British doctors. BMJ 1964; i:1399-410,1460-7
27Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994; 309:901-911
28Hackshaw A, Law M, Wald N. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315:980-988
29Copas J, Shi J. Reanalysis of epidemiological evidence on lung cancer and passive smoking. BMJ 2000; 320:417-418
30Williams C. lung cancer: The facts. Oxford: Oxford University Press, 1992.
31Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect. 1999; 107(supplement 2):289-98
33Kunitoh H. Sekine I. Kubota K et al. Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers. Cancer 1999; 86(7):1182-8
34Parkin D ed. Cancer incidence in five continent. vol 7. Lyon: International Agency for Research on Cancer, 1997
35Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer: 1999; 80:827-841
36Pisani P Parkin D, Bray F, Ferlay J. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Int J Cancer 1999; 83:18-29
37Botha H, Bright N, Needham P, Silcocks P. Trent cancer registry, Third annual report. Sheffield: Trent Cancer Registry, 1999.
38Mortality rates from lung cancer, 2000. Unpublished data obtained from the Trent Cancer Registry.
39Department of Health. Saving Lives: Our Healthier Nation. London: HMSO, 1999
40Department of Health. Smoking kills: a white paper on tobacco, London: HMSO, 1998
41Department of Health. The health of the nation: a strategy for health in England. London: HMSO, 1992.
42Kumar P, Clark M. Clinical medicine : a textbook for medical students and doctors. 4th ed. Edinburgh: W.B. Saunders, 1998.
43Dalmau J, Posner B. Paraneoplastic Syndromes. Arch Neurol 1999; 56(4): 405-408
44Antoine J, Absi L, Honnorat J et al. Antiamphysin Antibodies Are Associated With Various Paraneoplastic Neurological Syndromes And Tumours. Arch Neurol 1999; 56(2):172-177
45Templeton P, Caskey C, Zerhouni E. Current uses of CT and MR imaging in the staging of lung cancer. Radiol Clin North Am 1990; 28:631-646
46Hughes J. 18F-fluorodeoxyglucose PET scans in lung cancer. Thorax 1996; 51(2):S16-22
47Lacasse Y, Wong E, Guyatt G, Cook D. Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. Thorax 1999; 54(10):884-893.
48Patterson G et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999; 118(5):894-899
49George P. Fluorescence bronchoscopy for the early detection of lung cancer. Thorax 1999; 54(2):180-183
50Maeno T. Satoh H. Ishikawa H. et al. Does earlier detection of lung cancer on mass screening improve outcome in younger and middle-age patients? Oncol Rep 1998; 5(5): 1217-1219
51Melamed M, Flehinger B, Zamar M et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86, 44-53
52Fontana R, Sanderson D, Woolner L et al. lung cancer screening: The Mayo Program. J Occup Med 1986; 28:746-50
53Henschke C, McCauly D, Yakelevitz D et al. Early lung cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105 54 Dobson R. Screening trial for lung cancer planned for UK. BMJ 2000; 320:270
55Mountain C. Revisions in the International System for Staging lung cancer. Chest 1997; 111(6):1710-1717
56Mountain C. Clinical Biology of small cell carcinoma. Relationship to surgical therapy. Semin Oncol 1978; 5:272-9
57Non-small cell lung cancer collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised controlled trial. BMJ 1995; 311:899-909
58Hardy J, Noble T, Smith I. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer 1989; 60(5):764-766
59Burkitt H, Quick C, Gatt D. Essential Surgery: problems, diagnosis and management. Churchill Livingstone 2nd ed. London: 1996
60National Cancer Institute. Physician Data Query: Treatment: Non Small Cell lung cancer. http://www.medsc.com/pdq/nonsmallcell_pro.html
61Edell E, Cortese D. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102(5):1319-1322
62Gauden S, Ramsay J, Tripeony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995; 108(5):1278-1282
63PORT meta-analysis Trialists Group: Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998; 352(9124):257-263
64Komaki R, Cox J, Hartz A et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol 1985; 8(5):362-370
65Johnson D, Einhorn L, Bartolucci A et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, non-resectable non-small cell lung cancer. Ann Intern med 1990; 113(1):33-38
66Komaki R, Mountain CF, Holbert J et al. Superior Sulcus Tumours: Treatment Selection And Results For 85 Patients Without Distant Metastasis (M0) At Presentation. Int J Radiat Oncol Biol Phys 1990; 19(1):31-36
67Van Raemdock D, Schneider A Ginsberg R: surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg 1992; 54(5):999-1013
68National Cancer Institute. Physician Data Query: Treatment: Small Cell lung cancer. http://www.medsc.com/pdq/smallcell_pro.html
69Ajedi A, Marks R, Bonner J. Current guidelines for the Management of Small Cell lung cancer. Mayo Clin Proc 1999; 74(8):809-816
70Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973; 4(2):31-42
71Arrigada R, LeChevalier T, Borie F et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995; 87:183-190
72Salgia R, Skarin A, Elias A. Management of limited stage small-cell lung cancer. Adv Oncol. 1996; 12:8-15
73The ATBC Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035.
74Omenn GS, Goodman GE, Thornquist M, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-1155
75Pastori U, Infante M, Maioli M et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11(7):1216-1222
76Lippman S. University of Texas – MD Anderson Cancer Center: Phase III, Double Blind, Randomized Controlled trial of 13-CRA vs placebo to prevent second primary tumours in Patients with Totally resected Stage I non-small cell lung cancer (Sumary last modified 07/97), MDA-ID-91025, clinical trial, closed, 04/09/1997.
77O’Neill B, Fallon M. ABC of palliative care: Principles of palliative care and pain control. British Medical Journal 1997; 315:801-804
78Sarafino P. Health Psychology: biopsychosocial interactions 3rd ed. Chichester: Wisley, 1998.
79The effect of psychosocial factors on lung cancer mortality at one year. Stavraky K, Donner A, Kincade J, Stewart M. J Clin Epidemil 1999; 41(1):75-82
80Kubler-Ross, E. On Death and Dying. London: Tavistock, 1970
81Raw M, McNeill A, West R. Smoking Cessation Guidelines for Health Professionals: A guide to effective smoking cessation interventions for the health care system. Thorax 1998; 53(5S):1S-19S
82Al-Moundhri M, O'Brien M, Souberbielle B. Immunotherapy of lung cancer. Br J Cancer 1998; 78(3):282-288
Department of Pathology, Glenfield General Hospital, Glenfield, Leicester, UK.
Glenfield General Hospital, Glenfield, Leicester, UK.
Glenfield General Hospital, Glenfield, Leicester, UK.
Knighton Street Offices, Leicester Royal Infirmary, Leicester, UK.
My homepage has links to all my other sites
New Leaf (UK) Ltd Outside Broadcast Professional Events UK Mobile Disco Radzoule Mobile Disco UK live bands mobile professional Discos dj search find live bands corporate entertainment effects local uk with original music from the 60s 70s 80s 90s functions. We can cater for parties from 30 people to 3000. The professionals disco can cater for formal functions, balls, weddings, birthday parties, corporate evnts disco, mobile, uk, disco, discos, mobile, music, dj, dj, uk, south, london, london, UK, england, live, bands, live, band, live band, functions, live bands, wedding entertainment, parties, party, original, corporate events, corporate entertainment, music, 60s, 70s, 80s, 90s, formal, functions, balls, weddings, birthday parties, you don't need an excusehire, discotheque, discotheque, formal, occasion, disc, jokey, loud, quality, fun, cheap, balls, party, black tie, functions, exclusive, corporate, wedding outside broadcast